Stocks股票 / Health Care / MRNA
MRNA US listed · USD美股 · 美元
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.莫德纳公司是一家美国制药和生物技术公司,总部位于马萨诸塞州剑桥,专注于RNA疗法,主要是mRNA疫苗。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-08-07Estimates being raised — 1 analysts预期上调 — 1 位分析师
Valuation估值
Expensive vs sector相对行业偏贵| Multiple指标 | MRNA | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 2.71x | 3.44 | |
| P/S市销率 | 12.06x | 2.97 | |
| Earnings yield盈利收益率 | -12.04% | 2.72 | |
| FCF yield自由现金流收益率 | -8.81% | 4.00 | |
| Shareholder yield股东收益率 | 0.01% | 1.89 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Options positioning期权持仓
as of last close截至上一收盘Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$9.3M net (0 buyers, 4 sellers)-$9.3M 净值(0 买家,4 卖家)
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Perceptive Advisors | A | New position新建仓 | 1.0% | 2026-03-31 |
| Casdin Capital | B | New position新建仓 | 0.3% | 2026-03-31 |
| Coatue Management | A | exitexit | 0.0% | 2026-03-31 |
Signal history信号历史
engine events引擎事件Company profile公司档案
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.莫德纳公司是一家美国制药和生物技术公司,总部位于马萨诸塞州剑桥,专注于RNA疗法,主要是mRNA疫苗。
- Inventory build
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 2.7× | 3.4× | 63% |
| Price / Sales市销率 | 12.1× | 3.0× | 8% |
| Earnings yield盈利收益率 | -12.0% | 2.7% | 8% |
| Free-cash-flow yield自由现金流收益率 | -8.0% | 5.5% | 3% |
| Shareholder yield股东综合回报率 | 0.0% | 1.9% | 11% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -11.2% | -0.9% |
| 1 Month近1月 | -7.0% | -0.6% |
| 3 Months近3月 | +9.7% | +5.4% |
| 6 Months近6月 | +19.4% | +8.6% |
| Year to date年初至今 | +92.8% | +8.9% |
| 1 Year近1年 | +90.3% | +19.2% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $803M | $18.5B | $19.3B | $6.8B | $3.2B | $1.9B |
| EPS每股收益 | $-1.96 | $28.29 | $20.12 | $-12.33 | $-9.28 | $-7.26 |
| Free cash flow自由现金流 | $2.0B | $13.3B | $4.6B | $-3.8B | $-4.1B | $-2.1B |
| Gross margin毛利率 | 99.0% | 85.8% | 71.9% | 31.5% | 54.8% | 55.3% |
| Net margin净利率 | -93.0% | 66.1% | 43.4% | -68.8% | -110.0% | -145.2% |
| FCF margin自由现金流利润率 | 243.9% | 72.2% | 23.8% | -55.9% | -125.3% | -106.2% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: accruals trending up over 6 fiscal years — earnings increasingly not cash-backed盈利质量:应计利润在 6 个财年间走高——盈利的现金支撑减弱
- Working capital: inventory +229% vs sales +142% — inventory building, demand risk营运资本:存货 +229% 对销售 +142%——存货积压,需求风险
- Pricing power: gross margin −43.7pts over 6 years定价能力:毛利率 6 年下降 43.7 个百分点
- Capital discipline: investment near the peer median资本纪律:投资力度接近同业中位
- Balance sheet: Altman Z 4.41 — safe zone资产负债表:Altman Z 4.41——安全区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Estimate revisions预期修正
Dealer positioning map做市商持仓地图
Volatility pricing波动率定价
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Perceptive Advisors | A | New position新建仓 | 1.0% | $51M |
| Casdin Capital | B | New position新建仓 | 0.3% | $4M |
| Coatue Management | A | Exited清仓 | 0.0% | $6M |